It also included genes with mutations and proteins with altered expression both associated with cancer metabolic reprogramming, IG1R/AKT signalling in breast cancer, metabolism of thyroid hormones in adipose tissue, glutamine in cancer and overall mTOR/p53 mediated cell metabolism. This evidence concerns the gene TP53 and breast cancer.